NTNU Intranasal Naloxone Trial (NINA-1) Study documents
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'This section contains study documents forming the basis of the NINA-1 Trial. Documents will be added at Sponsors discretion, and aim to reflect the Trial Master File. Please consult the file 00readme for a key to how documents are coded in this dataset. If you have any specific document you would like access to, please contact us, and Sponsor will consider publication. Some documents will be altered to facilitate open publication. In such case this will be clearly marked.All documents are combined with approved translations into English and original document in Norwegian where necessary.The NINA-1 Trial is a phase 3 drugs trial of nasal naloxone. It is double-blinded, double dummy, randomised controlled trial, two-centre study, non-inferiority design. The centres are Oslo University Hospital and St Olav’s Hospital, U' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Administration, Intranasal","Consent Forms","Drug Overdose","Injections, Intramuscular","Naloxone","Narcotic Antagonists","Randomized Controlled Trials as Topic","Vulnerable Populations"]} <|eot_id|>
 Here is the Description of a dataset. Description:'This section contains study documents forming the basis of the NINA-1 Trial. Documents will be added at Sponsors discretion, and aim to reflect the Trial Master File. Please consult the file 00readme for a key to how documents are coded in this dataset. If you have any specific document you would like access to, please contact us, and Sponsor will consider publication. Some documents will be altered to facilitate open publication. In such case this will be clearly marked.All documents are combined with approved translations into English and original document in Norwegian where necessary.The NINA-1 Trial is a phase 3 drugs trial of nasal naloxone. It is double-blinded, double dummy, randomised controlled trial, two-centre study, non-inferiority design. The centres are Oslo University Hospital and St Olav’s Hospital, U' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
This section contains study documents forming the basis of the NINA-1 Trial. Documents will be added at Sponsors discretion, and aim to reflect the Trial Master File. Please consult the file 00readme for a key to how documents are coded in this dataset. If you have any specific document you would like access to, please contact us, and Sponsor will consider publication. Some documents will be altered to facilitate open publication. In such case this will be clearly marked.All documents are combined with approved translations into English and original document in Norwegian where necessary.The NINA-1 Trial is a phase 3 drugs trial of nasal naloxone. It is double-blinded, double dummy, randomised controlled trial, two-centre study, non-inferiority design. The centres are Oslo University Hospital and St Olav’s Hospital, U
Administration, Intranasal; Consent Forms; Drug Overdose; Injections, Intramuscular; Naloxone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Vulnerable Populations